Download presentation

Presentation is loading. Please wait.

Published byDion Lassiter Modified over 3 years ago

1
Is a “Discussion” on “Are Observational Studies Any Good” Any Good Don Hoover May 2, 2014 1

2
Everyone Already Knows Observational Studies Are Not Perfect … Right? But who thinks – the real type 1 error is 0.55 when the nominal is 0.05? – The real coverage of a 95% confidence interval is 25%? – That’s what David Madigan and the OMAP team find This obviously makes such results meaningless But how many papers with these properties are being (and will continue to be) published ??? 2

3
But Does David’s Talk Really Apply to ALL Observational Studies? They Only Look at Observational Studies of Drug Use and Adverse Consequences There’s other kinds of Observational Studies … on HIV, Epi, Health Behaviors, Nutrition, etc. – No one has looked at these types of studies These other studies must have similar problems Maybe at a smaller magnitude – But there are no “negative controls” for these settings … so no one can check this 3

4
The Approach here is Creative and Innovative Finding Negative Control Exposures or Outcomes to derive empirical distribution of the test statistic somewhat equalizes assumptions and unmeasured confounding With a given Drug Use as the exposure and a given Disease the outcome, such negative controls are readily available in many data sets So maybe something like it should be used when possible But now some questions …… 4

5
Q1- Why were Negative Control Drugs More Associated With Outcomes than by Chance? People put on Any Drug are Sicker? Those receiving a negative (control) drug are more likely to receive some other positive drug? Those apriori more likely to have a given disease outcome are steered to the negative drugs? Incorrect statistical models used? 5

6
Q2- Is this Approach Practical? A lot more work to fit many models than the standard approach which only fits one – More money as well - A grant application using it would be less likely to get funded – More work also means more chance for error in implementation 6

7
Q3 – How does one interpret a positive drug with empirical P < 0.05? 7 Positive Drug with empirical P < 0.05 The use of an “empirical” approach acknowledges we do not know what is going on so maybe the P < 0.05 is from model artifact not causal Calibrated Normal Scores of Negative Controls

8
Q4 – What is done with “Negative Drugs” more extreme than the Positive One 8 Calibrated Normal Scores of Negative Controls Positive Drug with P < 0.05 Should these Negative Controls all be Examined for Causal Association as their Signal is larger than the positive drug?

9
Q5 - How to handle Heterogeneity in Denominator of Calibration Statistic 9 Variance may introduce Apples to Oranges comparisons especially if although such does not appear to be the case in the examples David used From Schumie … Madigan Stat Med 2014 33; 209-18

Similar presentations

OK

Once you know the correlation coefficient for your sample, you might want to determine whether this correlation occurred by chance. Or does the relationship.

Once you know the correlation coefficient for your sample, you might want to determine whether this correlation occurred by chance. Or does the relationship.

© 2018 SlidePlayer.com Inc.

All rights reserved.

To ensure the functioning of the site, we use **cookies**. We share information about your activities on the site with our partners and Google partners: social networks and companies engaged in advertising and web analytics. For more information, see the Privacy Policy and Google Privacy & Terms.
Your consent to our cookies if you continue to use this website.

Ads by Google

Ppt on information security awareness Ppt on as 14 amalgamation and capital Ppt on credit default swaps quotes Ppt on bluetooth communication Ppt on metallic and nonmetallic minerals Ppt on eye oscillation Ppt on personality development for mba students Ppt on cse related topics about economics Ppt on cold call teach like a champion Ppt on success and failure image